Bristol-Myers Squibb (NYSE: BMY)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Raymond James on Monday, June 6, 2022. The analyst firm set a price target for 0.00 expecting BMY to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $76.88 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.54 per share of Class A Common Stock. The quarterly cash dividend was payable on August 1, 2022 to stockholders of record on June 30, 2022.
Bristol-Myers Squibb’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.